Time-dependent activation of c-fos in limbic brain areas by ocular administration of nerve growth factor in adult rats

Journal of Ocular Pharmacology and Therapeutics

Volumn 27, Issue 3, 2011, Pages 209-218

  Calza, Arianna ^a   Florenzano, Fulvio ^a,b   Pellegrini, Daniela ^a   Tirassa, Paola ^a,b  

^a CNR   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; NERVE GROWTH FACTOR; NEURON SPECIFIC NUCLEAR PROTEIN; NEUROTROPHIN; PROTEIN C FOS;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN DEPTH STIMULATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; FRONTAL CORTEX; FROZEN SECTION; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATERAL GENICULATE NUCLEUS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; VISUAL CORTEX;

ANIMALS; BIOLOGICAL MARKERS; IMMUNOHISTOCHEMISTRY; LIMBIC SYSTEM; MALE; MICE; NERVE GROWTH FACTOR; NERVE TISSUE PROTEINS; NEURONS; OPHTHALMIC SOLUTIONS; ORGAN SPECIFICITY; PROTEIN DENATURATION; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SPECIFIC PATHOGEN-FREE ORGANISMS; SYNAPTIC TRANSMISSION; TIME FACTORS; UP-REGULATION;

EID: 79958794023     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2010.0139     Document Type: Article

References (51)

1. Connor, B., and Dragunow, M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev. 27:1-39, 1998. (Pubitemid 28300281)
2. Sofroniew, M.V., Howe, C.L., and Mobley, W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24:1217-1281, 2001. (Pubitemid 32695259)
3. Zhao, H.M., Liu, X.F., Mao, X.W., and Chen, C.F. Intranasal delivery of nerve growth factor to protect the central nervous system against acute cerebral infarction. Chin. Med. Sci. J. 19:257-261, 2004.
4. De Rosa, R., Garcia, A.A., Braschi, C., Capsoni, S., et al. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 102:3811-3816, 2005. (Pubitemid 40360709)
5. Shi, C.G., Wang, L.M., Wu, Y., Wang, P., et al. Intranasal administration of nerve growth factor produces antidepressant- like effects in animals. Neurochem. Res. 35:1302-1314, 2010.
6. Eriksdotter Jonhagen, M., Nordberg, A., Amberla, K., Backman, L., et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimers disease. Dement. Geriatr. Cogn. Disord. 9:246-257, 1998. (Pubitemid 28377225)
7. Tuszynski, M.H., Thal, L., Pay, M., Salmon, D.P., et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 11:551-555, 2005. (Pubitemid 40691288)
8. Apfel, S.C., Schwartz, S., Adornato, B.T., Freeman, R., et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 284:2215-2221, 2000.
9. Tuveri, M., Generini, S., Matucci-Cerinic, M., and Aloe, L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 356:1739-1740, 2000.
10. Lambiase, A., Aloe, L., Centofanti, M., Parisi, V., et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma. Proc. Natl. Acad. Sci. U.S.A. 2009 [Epub ahead of print]. DOI: 10.1073/pnas.0906678106.
11. Lambiase, A., Rama, P., Bonini, S., Caprioglio, G., et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N. Engl. J. Med. 338:1174-1180, 1998. (Pubitemid 28180745)
12. Lambiase, A., Coassin, M., Tirassa, P., Mantelli, F., et al. Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report. Ann. Ist Super Sanita. 45:439-442, 2009.
13. Lambiase, A., Tirassa, P., Micera, A., Aloe, L., et al. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest. Ophthalmol. Vis. Sci. 46:3800-3806, 2005. (Pubitemid 44264689)
14. Lambiase, A., Centofanti, M., Micera, A., Manni, G.L., et al. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes. Arch. Clin. Exp. Ophthalmol. 235:780-785, 1997. (Pubitemid 27514275)
15. Sposato, V., Bucci, M.G., Coassin, M., Russo, M.A., et al. Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma. Neurosci. Lett. 446:20-24, 2008.
16. Colafrancesco, V., Parisi, V., Sposato, V., Rossi, S., et al. Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma. J. Glaucoma. 20:100-108, 2010.
17. Sposato, V., Parisi, V., Manni, L., Antonucci, M.T., et al. Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: effect of eye NGF application. Vision Res. 49:54-63, 2009.
18. Di Fausto, V., Fiore, M., Tirassa, P., Lambiase, A., et al. Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain. Eur. J. Neurosci. 26:2473-2480, 2007. (Pubitemid 350050448)
19. Lambiase,A., Pagani, L., Di Fausto,V., Sposato, V., et al. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res. 1127:45-51, 2007. (Pubitemid 44873000)
20. Olson, L. NGF and the treatment of Alzheimers disease. Exp. Neurol. 124:5-15, 1993.
21. Tuszynski, M.H., and Blesch, A. Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimers disease. Prog. Brain Res. 146:441-449, 2004. (Pubitemid 37547925)
22. Apfel, S.C. Neurotrophic factor therapy-prospects and problems. Clin. Chem. Lab. Med. 39:351-355, 2001.
23. Yamada, K., Nitta, A., Hasegawa, T., Fuji, K., et al. Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimers disease. Behav. Brain Res. 83:117-122, 1997. (Pubitemid 27086623)
24. Chen, X.Q., Fawcett, J.R., Rahman, Y.E., Ala, T.A., et al. Delivery of nerve growth factor to the brain via the olfactory pathway. J. Alzheimers Dis. 1:35-44, 1998.
25. Tirassa, P., Manni, L., Aloe, L., and Lundeberg, T. Cholecystokinin- 8 and nerve growth factor: two endogenousmolecules working for the upkeep and repair of the nervous system. Curr. Drug Targets CNS Neurol. Disord. 1:495-510, 2002.
26. Lazarovici, P., Marcinkiewicz, C., and Lelkes, P.I. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr. Pharm. Des. 12:2609-2622, 2006.
27. Aloe, L., Tirassa, P., and Lambiase, A. The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers. Pharmacol. Res. 57:253-258, 2008
28. Bocchini, V., and Angeletti, P.U. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc. Natl. Acad. Sci. U.S.A. 64:787-794, 1969.
29. Paxinos, G., and Watson, C. The Rat Brain in Stereotaxic Coordinates. Academic Press: Australia; 1997.
30. Hattar, S., Kumar, M., Park, A., Tong, P., et al. Central projections of melanopsin-expressing retinal ganglion cells in the mouse. J. Comp. Neurol. 497:326-349, 2006. (Pubitemid 43865789)
31. Moga, M.M., Weis, R.P., and Moore, R.Y. Efferent projections of the paraventricular thalamic nucleus in the rat. J. Comp. Neurol. 359:221-238, 1995.
32. McNaughton, L.A., and Hunt, S.P. Regulation of gene expression in astrocytes by excitatory amino acids. Brain Res. Mol. Brain Res. 16:261-266, 1992. (Pubitemid 23035969)
33. Labie, C., Lafon, C., Marmouget, C., Saubusse, P., et al. Effect of the neuroprotective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortex. Br. J. Pharmacol. 127:139-144, 1999. (Pubitemid 29213242)
34. Ambati, J., Canakis, C.S., Miller, J.W., Gragoudas, E.S., et al. Diffusion of high molecular weight compounds through sclera. Invest. Ophthalmol. Vis. Sci. 41:1181-1185, 2000. (Pubitemid 30187558)
35. Koevary, S.B., Lam, V., Patsiopoulos, G., and Lake, S. Accumulation of porcine insulin in the rat brain and cerebrospinal fluid following ocular application. J. Ocul. Pharmacol. Ther. 19:377-384, 2003. (Pubitemid 37013011)
36. Koevary, S.B., Lam, V., and Patsiopoulos, G. Pharmacokinetics of insulin uptake by ocular tissues and the role of cerebrospinal fluid in optic nerve insulin accumulation following topical insulin application. Optometry 75:183-188, 2004. (Pubitemid 39207392)
37. Vaka, S.R., Sammeta, S.M., Day, L.B., and Murthy, S.N. Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake. J. Pharm. Sci. 98:3640-3646, 2009.
38. Vereczki, V., Koves, K., Csaki, A., Grosz, K., et al. Distribution of hypothalamic, hippocampal and other limbic peptidergic neuronal cell bodies giving rise to retinopetal fibers: anterograde and retrograde tracing and neuropeptide immunohistochemical studies. Neuroscience 140:1089-1100, 2006.
39. Baker, H., and Spencer, R.F. Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat. Exp. Brain Res. 63:461-473, 1986. (Pubitemid 16036221)
40. Carmignoto, G., Comelli, M.C., Candeo, P., Cavicchioli, L., et al. Expression of NGF receptor and NGF receptor mRNA in the developing and adult rat retina. Exp. Neurol. 111:302-311, 1991.
41. Colafrancesco, V., Cirulli, F., Rossi, S., Berry, A., et al. Anti- NGF-antibody administration as collyrium reduces the presence of NGF and enhances the expression of VEGF in the retina, lacrimal gland and hippocampus. Neurosci. Lett. 463:203-206, 2009.
42. Hattar, S., Liao, H.W., Takao, M., Berson, D.M., et al. Melanopsin- containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 295:1065-1070, 2002. (Pubitemid 34132235)
43. Vandewalle, G., Maquet, P., and Dijk, D.J. Light as a modulator of cognitive brain function. Trends Cogn. Sci. 13:429-438, 2009.
44. Cirulli, F., and Alleva, E. The NGF saga: from animal models of psychosocial stress to stress-related psychopathology. Front. Neuroendocrinol. 30:379-395, 2009.
45. Berry, A., Aloe, L., Rossi, S., Bonsignore, L.T., et al. Conjunctivally administered NGF antibody reduces pain sensitivity and anxiety-like behavioral responses in aged female mice. Behav. Brain Res. 210:284-287, 2010.
46. Inglis, F.M., and Fibiger, H.C. Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli. Neuroscience 66:81-86, 1995.
47. Stoehr, J.D., Mobley, S.L., Roice, D., Brooks, R., et al. The effects of selective cholinergic basal forebrain lesions and aging upon expectancy in the rat. Neurobiol. Learn. Mem. 67:214-227, 1997. (Pubitemid 27424458)
48. Dalley, J.W., Theobald, D.E., Bouger, P., Chudasama, Y., et al. Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex. Cereb. Cortex 14:922-932, 2004. (Pubitemid 38971466)
49. Laplante, F., Morin, Y., Quirion, R., and Vaucher, E. Acetylcholine release is elicited in the visual cortex, but not in the prefrontal cortex, by patterned visual stimulation: a dual in vivo microdialysis study with functional correlates in the rat brain. Neuroscience 132:501-510, 2005. (Pubitemid 40417921)
50. Dotigny, F., Ben Amor, A.Y., Burke, M., and Vaucher, E. Neuromodulatory role of acetylcholine in visually-induced cortical activation: behavioral and neuroanatomical correlates. Neuroscience 154:1607-1618, 2008.
51. Chudasama, Y., Dalley, J.W., Nathwani, F., Bouger, P., et al. Cholinergic modulation of visual attention and working memory: dissociable effects of basal forebrain 192-IgG-saporin lesions and intraprefrontal infusions of scopolamine. Learn. Mem. 11:78-86, 2004. (Pubitemid 38167061)